- Health & Pharmaceuticals›
- State of Health›
Medicare and Medicaid costs from individuals with Alzheimer's in the U.S. 2019-2050
Medicare and Medicaid costs from individuals with Alzheimer's in the U.S. 2019-2050
Costs of care for individuals in the U.S. with Alzheimer's disease to Medicare and Medicaid from 2019 to 2050 (in billion U.S. dollars)
by John Elflein,
last edited
May 21, 2019
This graph presents the costs of care for individuals with Alzheimer's disease to Medicare and Medicaid in the U.S. from 2019 to 2050. In 2019, Alzheimer's disease was estimated to cost Medicare and Medicaid around 195 billion dollars in care costs. This number is expected to grow to approximately 770 billion dollars by 2050.
Costs of care for individuals in the U.S. with Alzheimer's disease to Medicare and Medicaid from 2019 to 2050 (in billion U.S. dollars)
Loading statistic...
| Care costs in billion U.S. dollars | |
|---|---|
| 2050 | 770 |
| 2045 | 623 |
| 2040 | 517 |
| 2035 | 409 |
| 2030 | 315 |
| 2025 | 241 |
| 2019 | 195 |
| Care costs in billion U.S. dollars | |
|---|---|
| 2050 | 770 |
| 2045 | 623 |
| 2040 | 517 |
| 2035 | 409 |
| 2030 | 315 |
| 2025 | 241 |
| 2019 | 195 |
© Statista 2019
About this statistic
Source: Alzheimer's Association
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by John Elflein,
last edited
May 21, 2019
This graph presents the costs of care for individuals with Alzheimer's disease to Medicare and Medicaid in the U.S. from 2019 to 2050. In 2019, Alzheimer's disease was estimated to cost Medicare and Medicaid around 195 billion dollars in care costs. This number is expected to grow to approximately 770 billion dollars by 2050.
- Source
- Alzheimer's Association
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- March 2019
- Region
- United States
- Survey time period
- as of March 2019
Source
- Source
- Alzheimer's Association
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- March 2019
More information
- Region
- United States
- Survey time period
- as of March 2019
Other statistics on the topic
Alzheimer's disease and other dementias
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Alzheimer's and other dementias
- 94 page/s
- English
- pptx
- Detailed references
Everything On "Alzheimer's and other dementias" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Alzheimer's and other dementias"
- Global overview
The most important statistics
- Leading causes of death worldwide in 2016 (in millions)Global death rate - leading causes 2016
- Estimated number of people with dementia worldwide in 2018, 2030, and 2050 (in millions)Number of dementia sufferers worldwide 2018-2050
- Global cost estimates for dementia care from 2018 to 2030 (in trillion U.S. dollars)Dementia care expenditure forecast worldwide 2018-2030
- Probability of success for Alzheimer's drug clinical trials worldwide from 2008 to 2019, by phaseAlzheimer's disease clinical trials success rate globally from 2008-2019, by phase
- Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase
- United States
The most important statistics
- Percentage of U.S. adults who stated they were concerned they may develop the following diseases in their lifetime as of 2018Diseases U.S. adults were concerned about developing as of 2018
- Percentage of U.S. adults aged between 50 and 64 years old who were worried about developing dementia as of 2018Share of U.S. adults aged 50-64 worried about developing dementia
- Estimated lifetime risks for Alzheimer’s in the U.S. as of 2015, by age and genderAlzheimer's in the U.S: lifetime risks, by age and gender
- Distribution of Alzheimer's disease patients in the United States as of 2019, by age groupShare of patients with Alzheimer's disease in the U.S. by age group 2019
- Rates of the 10 leading causes of death in the United States in 2017 (per 100,000 population)*Rates of the leading causes of death in the U.S. 2017
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by diseasePercentage changes in selected causes of death in the U.S. 2000-2017
- Total Alzheimer's disease funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)Total Alzheimer's disease funding by National Institutes for Health 2013-2019
- U.S. states
The most important statistics
- Number of deaths attributed to dementia in the U.S. in 2017, by stateDeaths attributed to dementia in the U.S. in 2017, by state
- Rate of death for dementia in the U.S. in 2017, by state (per 100,000 population)Dementia death rates in the U.S. in 2017, by state
- Leading U.S. states by number of deaths due to Alzheimer's in 2017Leading U.S. states by number of deaths due to Alzheimer's 2017
- Leading U.S. states by Alzheimer's death rate in 2017 (per 100,000 population)Alzheimer's death rate in the U.S. - leading states 2017
- Projected number of people aged 65 and over with Alzheimer's disease in the U.S. in 2019 and 2025, by state (in thousands)Total number of Alzheimer's disease elderly patients U.S. by state 2019 and 2025
- Projected change of U.S. adults aged 65 and over with Alzheimer's disease between 2019 and 2025, by statePercent change in Alzheimer's disease elderly patients U.S. by state 2019-2025
- Costs
The most important statistics
- Costs of care for individuals in the U.S. with Alzheimer's disease to Medicare and Medicaid from 2019 to 2050 (in billion U.S. dollars)Medicare and Medicaid costs from individuals with Alzheimer's in the U.S. 2019-2050
- Average annual per-person payments for health and long term care services with and without Alzheimer's or other dementias in the U.S. as of 2018, by payment sourcePayments for health services with and without Alzheimer's U.S. 2018 by payment source
- U.S. aggregate care costs for older people with Alzheimer‘s or other dementias from 2011 to 2019, by payer (in billion U.S. dollars)*Older people with Alzheimer or dementia: U.S. aggregate care costs 2011-2019
- Percentage of U.S. aggregate care costs for older people with Alzheimer‘s or other dementias from 2011 to 2019, by payer*Distribution of U.S. care costs for older people with Alzheimer 2011-2019 by payer
- Annual mean payment per Medicare beneficiary aged 65 and older with and without Alzheimer's or dementia as of 2018 (in U.S. dollars)Mean payment per elderly Medicare beneficiary with and without Alzheimer's U.S. 2018
- Annual mean payment per Medicare beneficiary aged 65 and older with and without Alzheimer's or dementia as of 2018, by coexisting condition (in U.S. dollars)Cost per elderly Medicare beneficiary with and without Alzheimer's by condition 2018
- Care/caregiving
The most important statistics
- Percentage of caregivers that stated their care recipient suffered from select conditions in the U.S. as of 2017Leading health conditions of care recipients as cited by U.S. caregivers as of 2017
- Caregivers of Alzheimer's and dementia patients with work-related changes in the U.S. in 2017Share of caregivers for Alzheimer's and dementias with work-related change U.S. 2017
- Age distribution of Alzheimer and other dementia caregivers in the U.S. in 2019Ages of Alzheimer/dementia caregivers in the U.S. in 2019
- Leading U.S. states by number of Alzheimer and dementia caregivers as of 2018 (in thousands)Leading U.S. states by number of Alzheimer/dementia caregivers 2018
- Key figures on Alzheimer and other dementia caregivers' unpaid care in the U.S. from 2011 to 2018 (in millions)*Alzheimer and other dementia caregivers' unpaid care in the U.S. 2011-2018
- Leading U.S. states by hours of unpaid care given by Alzheimer and dementia caregivers in 2018 (in millions of hours)Leading U.S. states by unpaid care given by Alzheimer/dementia caregivers 2018
- Leading U.S. states by value of unpaid care given by Alzheimer/dementia caregivers in 2018 (in million U.S. dollars)Leading U.S. states by value of unpaid care given by dementia caregiver 2018
- Deaths from dementia
The most important statistics
- Number of deaths attributed to dementia in the U.S. from 2000 to 2017Deaths attributed to dementia in the U.S. 2000-2017
- Number of deaths attributed to dementia in the U.S. from 2000 to 2017, by genderDeaths attributed to dementia in the U.S. by number 2000-2017, by gender
- Rate of death for dementia in the U.S. in 2017, by gender (per 100,000 population)Dementia death rates in the U.S. in 2017, by gender
- Rate of death for dementia in the U.S. in 2017, by age (per 100,000 population)Dementia death rates in the U.S. in 2017, by age
- Rate of death for dementia in the U.S. in 2017, by ethnicity (per 100,000 population)Dementia death rates in the U.S. in 2017, by ethnicity
- Distribution of deaths attributed to dementia in the U.S. from 2010 to 2017, by type of dementiaDistribution of dementia deaths in the U.S. 2010-2017, by type of dementia
- Number of deaths attributed to dementia in the U.S. in 2017, by type of dementiaDeaths attributed to dementia in the U.S. in 2017, by type of dementia
- Alzheimer's disease mortality rate in the United States from 2000 to 2017 (per 100,000 population)Death rate due to Alzheimer's Disease in the U.S. 2000-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Projected annual Medicare & Medicaid spending on Alzheimer's 2010-2050
- Medicare: possible savings 2021 through selected measures
- Diabetes in the U.S. - emergency department visits for adults by payer 2010
- U.S. physicians' positions on Medicare and Medicaid patients 2018
- Attitude towards the health care legislation in the U.S. in 2011 by generation
- CMS add-on payments proposed for select medical devices 2017
- Health program outlays by U.S. Centers for Medicare and Medicaid Services 2010-2020
- Health program outlays by CMS Mandatory 2010-2020
- Health program outlays by U.S. CMS Discretionary 2010-2020
- Loss due to major Medicare and Medicaid fraud in the U.S. 2010-2016
- Payments for health services by Alzheimer's or dementia patients in the U.S. 2015
- Number of deaths from Alzheimer's in Spain 2005-2015, by gender
- Alzheimer's patient number South Korea 2013-2024
- Hospital stays with/without Alzheimer's among older Medicare beneficiaries 2014
- Drugs for Alzheimer's disease sales in South Korea 2011-2016
- Number of Medicare-certified ambulatory surgery centers by state 2016
- Avoidable U.S. healthcare costs due to antiobiotics misuse by settings 2012
- Dispensed items with highest gross ingredient cost in NHS Scotland 2017/18
- Annual growth in health expenditure in Australia FY 2017 by area of expenditure
- Italy: perceived financial burden for pharmaceutical product purchase 2017
Statistics on "Alzheimer's and other dementias"
- Leading causes of death worldwide in 2016 (in millions)
- Estimated number of people with dementia worldwide in 2018, 2030, and 2050 (in millions)
- Global cost estimates for dementia care from 2018 to 2030 (in trillion U.S. dollars)
- Probability of success for Alzheimer's drug clinical trials worldwide from 2008 to 2019, by phase
- Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*
- Percentage of U.S. adults who stated they were concerned they may develop the following diseases in their lifetime as of 2018
- Percentage of U.S. adults aged between 50 and 64 years old who were worried about developing dementia as of 2018
- Estimated lifetime risks for Alzheimer’s in the U.S. as of 2015, by age and gender
- Distribution of Alzheimer's disease patients in the United States as of 2019, by age group
- Rates of the 10 leading causes of death in the United States in 2017 (per 100,000 population)*
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by disease
- Total Alzheimer's disease funding by the National Institutes for Health (NIH) from FY 2013 to FY 2019 (in million U.S. dollars)
- Number of deaths attributed to dementia in the U.S. in 2017, by state
- Rate of death for dementia in the U.S. in 2017, by state (per 100,000 population)
- Leading U.S. states by number of deaths due to Alzheimer's in 2017
- Leading U.S. states by Alzheimer's death rate in 2017 (per 100,000 population)
- Projected number of people aged 65 and over with Alzheimer's disease in the U.S. in 2019 and 2025, by state (in thousands)
- Projected change of U.S. adults aged 65 and over with Alzheimer's disease between 2019 and 2025, by state
- Costs of care for individuals in the U.S. with Alzheimer's disease to Medicare and Medicaid from 2019 to 2050 (in billion U.S. dollars)
- Average annual per-person payments for health and long term care services with and without Alzheimer's or other dementias in the U.S. as of 2018, by payment source
- U.S. aggregate care costs for older people with Alzheimer‘s or other dementias from 2011 to 2019, by payer (in billion U.S. dollars)*
- Percentage of U.S. aggregate care costs for older people with Alzheimer‘s or other dementias from 2011 to 2019, by payer*
- Annual mean payment per Medicare beneficiary aged 65 and older with and without Alzheimer's or dementia as of 2018 (in U.S. dollars)
- Annual mean payment per Medicare beneficiary aged 65 and older with and without Alzheimer's or dementia as of 2018, by coexisting condition (in U.S. dollars)
- Percentage of caregivers that stated their care recipient suffered from select conditions in the U.S. as of 2017
- Caregivers of Alzheimer's and dementia patients with work-related changes in the U.S. in 2017
- Age distribution of Alzheimer and other dementia caregivers in the U.S. in 2019
- Leading U.S. states by number of Alzheimer and dementia caregivers as of 2018 (in thousands)
- Key figures on Alzheimer and other dementia caregivers' unpaid care in the U.S. from 2011 to 2018 (in millions)*
- Leading U.S. states by hours of unpaid care given by Alzheimer and dementia caregivers in 2018 (in millions of hours)
- Leading U.S. states by value of unpaid care given by Alzheimer/dementia caregivers in 2018 (in million U.S. dollars)
- Number of deaths attributed to dementia in the U.S. from 2000 to 2017
- Number of deaths attributed to dementia in the U.S. from 2000 to 2017, by gender
- Rate of death for dementia in the U.S. in 2017, by gender (per 100,000 population)
- Rate of death for dementia in the U.S. in 2017, by age (per 100,000 population)
- Rate of death for dementia in the U.S. in 2017, by ethnicity (per 100,000 population)
- Distribution of deaths attributed to dementia in the U.S. from 2010 to 2017, by type of dementia
- Number of deaths attributed to dementia in the U.S. in 2017, by type of dementia
- Alzheimer's disease mortality rate in the United States from 2000 to 2017 (per 100,000 population)
- U.S. Alzheimer death rates among older people from 2000 to 2017, by age group
- Distribution of deaths in the U.S. from dementia in 2017, by location of death
- Projected annual Medicare & Medicaid spending on Alzheimer's, with and without new treatment advances 2010-2050 (in billion U.S. dollars)*
- Possible estimated Medicare savings in 2021 through selected measures
- Distribution of diabetes-related emergency department visits for U.S. adults in 2010, by expected primary payer
- Physicians' current positions regarding Medicare and Medicaid patients in 2018
- What should Congress do about the 2010 health care legislation?
- CMS maximum technology add-on payments proposed for select medical devices/products in the United States as of 2017 (in U.S. dollars)
- Health program outlays by the U.S. Centers for Medicare and Medicaid Services from 2010 to 2020 (in million U.S. dollars)
- Health program outlays by the CMS Mandatory in the U.S. from 2010 to 2020 (in million U.S. dollars)
- CMS Discretionary health programs outlays in the U.S. from 2010 to 2020 (in million U.S. dollars)
- Amount of money lost in major Medicare and Medicaid fraud cases in the U.S. from 2010 to 2016 (in million U.S. dollars)
- Average annual per-person payments for health and long-term care services for older people with Alzheimer's or other dementias in the U.S. as of 2015
- Number of deaths from Alzheimer's disease in Spain between 2005 and 2015, by gender
- Number of people with dementia in South Korea from 2013 to 2024 (in 1,000s)
- Hospital stays among older people with and without Alzheimer’s/dementia as of 2014, by coexisting condition (per 1,000 Medicare beneficiaries)
- Sales value of the medications for dementia based on the insurance benefits claimed in South Korea from 2011 to 2016 (in billion South Korean won)
- Number of Medicare-certified ambulatory surgery centers (ASCs) as of 2016, by state
- Avoidable antiobiotics misuse healthcare costs in the U.S. by settings of care in 2012 (in billion U.S. dollars)
- Items dispensed by NHS Scotland ranked by gross ingredient cost in financial year 2017/18 (in millions GBP)
- Annual growth in health expenditure in Australia in financial year 2017, by area of expenditure
- Perceived financial burden for pharmaceutical product purchase in Italy in 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.